This study provides valuable insights into the role of the NF-kB and IKK signaling pathways in γδ T cell development and survival, using robust genetic mouse models. While the research is ...

A new type of cancer cell that "warrants urgent investigation" has been discovered in childhood leukemia and could impact ...

LYL273 has demonstrated a 67% overall response rate, an 83% disease control rate, and a manageable safety profile at the ...

The discovery of new cancer cells with a switched-on gene called ZBTB16 is a breakthrough in childhood blood cancer research.

The immune system’s ability to mount an anti-tumor has long been recognized, and strategies to leverage the immune system to treat cancer were subsequently ...

Researchers identified a key receptor that primes the formation of autoreactive B cells. Disrupting this pathway may be a ...

Lyell Immunopharma, Inc. (Nasdaq: LYEL), a late-stage clinical company advancing a pipeline of next-generation CAR T-cell ...

Detailed price information for Caribou Biosciences Inc (CRBU-Q) from The Globe and Mail including charting and trades.

Authorization Received from UK and EU Authorities to Activate ex-US Clinical Trial Sites Supporting the Ongoing Patient Enrollment of FT819, an ...

New research suggests that DNA variants help predict toxicity and response in CAR T-cell therapy for large B-cell lymphoma.